Daito Pharmaceutical Co., Ltd. (4577.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥1,312 (-0.61%) as of
Key statistics
- Market cap
- 37.08B
- P/E (TTM)
- 12.27
- Forward P/E
- 6.08
- EPS (TTM)
- 106.94
- Dividend yield
- 3.41%
- 52-week range
- 1,120.00 – 1,521.00
- Beta
- 0.18
- Revenue (TTM)
- 49.53B
- Profit margin
- 6.39%
- Analyst target
- ¥1,390
- Volume
- 115.70k
About Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients (APIs) for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company also engages in wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. Daito Pharmaceutical Co., Ltd. was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co., Ltd. in 1992. Daito Pharmaceutical Co., Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Toyama, Japan
- Employees
- 1,085
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.